ENVA Enova International, Inc. Insider Trading

ENVA: Exec Chairman Fisher sells 10,256 shares for $1.6M via scheduled 10b5-1 plan

David Fisher, Executive Chairman of Enova International, Inc., executed 2 separate sales totaling 10,256 shares for $1,638,855.88 at blended average price $159.79 on May 21–22, 2026, pursuant to a pre-arranged 10b5-1 trading plan. This represents a scheduled transaction, not a discretionary decision. Post-transaction, Fisher holds 306,444 shares in non-derivative form, alongside derivative holdings of 249,318 shares (Non-Qualified Stock Option with limited SAR) and 246,242 shares (Non-Qualified Stock Option with limited SAR), indicating a substantial ongoing position in the company. At $159.05 current price, the stock is -10.0% from its 52-week high of $176.68 and -4.6% over the trailing 30 days, while ENVA's fundamentals remain solid: revenue of $875,142,000.00, net income of $91,099,000.00, annual revenue growth of +18.6%, and a P/E of 12.12. The transaction's scheduled nature and Fisher's retention of meaningful derivative and direct holdings provide limited insight into management conviction regarding near-term valuation.

Director William M Goodyear sold 6,231 shares of ENVA at $166.08 for $1,034,829.53

Director William M Goodyear sold 6,231 shares at $166.08 on 2026-05-18, reducing his holdings from 74,971 shares to 68,740 shares. The transaction value of $1,034,829.53 represents an 8.3% reduction in his pre-transaction holdings. At the current price of $164.59, the stock is trading 6.8% below its 52-week high of $176.68, while the company reports strong fundamentals with annual revenue growth of 18.6%, net income of $91,099,000.00, and a P/E of 12.54. The sale occurs in a context where the stock has risen 13.5% over the past 90 days, following a modest 0.4% decline over the past 30 days.

Executive Chairman David Fisher sells 20,000 ENVA shares for $3.5M; repeat seller with mixed timing on prior exits at this stock.

Executive Chairman David Fisher sold a significant block of Enova shares on 2026-05-07, reducing his holdings by over 6 percent. This is Fisher's 32nd open-market sale in the past three years—he has never purchased shares on the open market, establishing a pure seller profile throughout his tenure. At the 30-day horizon, Fisher's prior five exits at this stock show strong timing, with four of those sales preceding price declines; however, over a 90-day window the pattern reverses, with only one of those five prior sales proving well-timed and the other four followed by gains Fisher missed. This conflicting short-term vs. long-term timing record makes it difficult to read conviction from the current sale. Enova itself is financially healthy—a profitable company with growing revenues and a reasonable valuation—so this transaction appears to be portfolio management rather than a distress sale. The stock currently trades at its 52-week high, which is an unusually strong price point for an insider seller; most insider selling occurs during weakness.